CLINICAL_TRIALS
trial_result
· 2009-04-17
Clinical Trial Update: Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
This update reports the completion of a Phase 2 study of ONTAK (denileukin diftitox) in patients with B-cell chronic lymphocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Leukemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED